Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Gut Microbiota in Prediabetes and Diabetes: A Population-Based Cross-Sectional Study
Hao Wu, Valentina Tremaroli, Caroline Schmidt, et al.
Cell Metabolism (2020) Vol. 32, Iss. 3, pp. 379-390.e3
Open Access | Times Cited: 363

Showing 1-25 of 363 citing articles:

Gut microbiome and health: mechanistic insights
Willem M. de Vos, Herbert Tilg, Matthias Van Hul, et al.
Gut (2022) Vol. 71, Iss. 5, pp. 1020-1032
Open Access | Times Cited: 1424
Gut Microbiota and Short Chain Fatty Acids: Implications in Glucose Homeostasis
Piero Portincasa, Leonilde Bonfrate, Mirco Vacca, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1105-1105
Open Access | Times Cited: 536
Role and Mechanism of Gut Microbiota in Human Disease
Yinwei Chen, Jinghua Zhou, Li Wang
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 443
Trends in insulin resistance: insights into mechanisms and therapeutic strategy
Mengwei Li, Xiaowei Chi, Ying Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 405
Review of the relationships among polysaccharides, gut microbiota, and human health
Qianqian Song, Yikun Wang, L. Huang, et al.
Food Research International (2020) Vol. 140, pp. 109858-109858
Closed Access | Times Cited: 275
Personalized microbiome-driven effects of non-nutritive sweeteners on human glucose tolerance
Jotham Suez, Yotam Cohen, Rafael Valdés‐Mas, et al.
Cell (2022) Vol. 185, Iss. 18, pp. 3307-3328.e19
Open Access | Times Cited: 223
Gut microbial carbohydrate metabolism contributes to insulin resistance
Tadashi Takeuchi, Tetsuya Kubota, Yumiko Nakanishi, et al.
Nature (2023) Vol. 621, Iss. 7978, pp. 389-395
Open Access | Times Cited: 193
Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
Antonio Molinaro, Pierre Bel Lassen, Marcus Henricsson, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 184
Microbiome risk profiles as biomarkers for inflammatory and metabolic disorders
Amira Metwaly, Sandra Reitmeier, Dirk Haller
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 19, Iss. 6, pp. 383-397
Open Access | Times Cited: 168
Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications
Lin-Yong Zhao, Jia-Xin Mei, Gang Yu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 158
Conversion of dietary inositol into propionate and acetate by commensal Anaerostipes associates with host health
Thi Phuong Nam Bui, Louise Mannerås-Holm, Robert Puschmann, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 136
Precision nutrition: A systematic literature review
Daniel Kirk, Cagatay Catal, Bedir Teki̇nerdoğan
Computers in Biology and Medicine (2021) Vol. 133, pp. 104365-104365
Open Access | Times Cited: 134
Dynamics of the normal gut microbiota: A longitudinal one-year population study in Sweden
Lisa Olsson, Fredrik Boulund, Staffan Nilsson, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 5, pp. 726-739.e3
Open Access | Times Cited: 119
Gut Microbiota and Type 2 Diabetes Mellitus: Association, Mechanism, and Translational Applications
Lili Zhang, Jinjin Chu, Wenhao Hao, et al.
Mediators of Inflammation (2021) Vol. 2021, pp. 1-12
Open Access | Times Cited: 107
The gut microbiota-bile acid axis links the positive association between chronic insomnia and cardiometabolic diseases
Zengliang Jiang, Lai‐Bao Zhuo, Yan He, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 96
Synergy and oxygen adaptation for development of next-generation probiotics
Muhammad Tanweer Khan, Chinmay Dwibedi, Daniel Sundh, et al.
Nature (2023) Vol. 620, Iss. 7973, pp. 381-385
Open Access | Times Cited: 96
Impairment of gut microbial biotin metabolism and host biotin status in severe obesity: effect of biotin and prebiotic supplementation on improved metabolism
Eugeni Belda, Lise Voland, Valentina Tremaroli, et al.
Gut (2022) Vol. 71, Iss. 12, pp. 2463-2480
Open Access | Times Cited: 94
The gut microbiome: a core regulator of metabolism
Shiho Fujisaka, Yoshiyuki Watanabe, Kazuyuki Tobe
Journal of Endocrinology (2022) Vol. 256, Iss. 3
Open Access | Times Cited: 93
Gut microbiota: A new target for T2DM prevention and treatment
Lulu Liu, Jiheng Zhang, Yi Cheng, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 92
The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs
Marie Palmnäs-Bédard, Giuseppina Costabile, Claudia Vetrani, et al.
American Journal of Clinical Nutrition (2022) Vol. 116, Iss. 4, pp. 862-874
Open Access | Times Cited: 92
Fatty acid overproduction by gut commensal microbiota exacerbates obesity
Tadashi Takeuchi, Keishi Kameyama, Eiji Miyauchi, et al.
Cell Metabolism (2023) Vol. 35, Iss. 2, pp. 361-375.e9
Open Access | Times Cited: 89
Role of C-Reactive Protein in Diabetic Inflammation
Julijana Stanimirović, Jelena Radovanović, Katarina Banjac, et al.
Mediators of Inflammation (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 86
Gut bacterial metabolism contributes to host global purine homeostasis
Kazuyuki Kasahara, Robert L. Kerby, Qijun Zhang, et al.
Cell Host & Microbe (2023) Vol. 31, Iss. 6, pp. 1038-1053.e10
Open Access | Times Cited: 85
Type 2 diabetes mellitus-associated cognitive dysfunction: Advances in potential mechanisms and therapies
Ailin Luo, Zheng Xie, Yue Wang, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 137, pp. 104642-104642
Closed Access | Times Cited: 82
Butyrate to combat obesity and obesity‐associated metabolic disorders: Current status and future implications for therapeutic use
Thirza van Deuren, Ellen E. Blaak, Emanuel E. Canfora
Obesity Reviews (2022) Vol. 23, Iss. 10
Open Access | Times Cited: 81
Page 1 - Next Page

Scroll to top